SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-029005
Filing Date
2019-08-06
Accepted
2019-08-06 08:19:23
Documents
80
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xoma-10q_20190630.htm 10-Q 2119965
2 EX-10.1 xoma-ex101_307.htm EX-10.1 471559
3 EX-31.1 xoma-ex311_6.htm EX-31.1 15919
4 EX-31.2 xoma-ex312_8.htm EX-31.2 15924
5 EX-32.1 xoma-ex321_10.htm EX-32.1 7233
  Complete submission text file 0001564590-19-029005.txt   9124336

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT xoma-20190630.xml EX-101.INS 1637997
7 XBRL TAXONOMY EXTENSION SCHEMA xoma-20190630.xsd EX-101.SCH 102892
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xoma-20190630_cal.xml EX-101.CAL 52792
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20190630_def.xml EX-101.DEF 341568
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20190630_lab.xml EX-101.LAB 680298
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20190630_pre.xml EX-101.PRE 515280
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14710 | Film No.: 191000509
SIC: 2834 Pharmaceutical Preparations